Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Cedar Rapids, IA MSA — September 2026
Thin local biotech bench forces outsourcing over recruiting in Cedar Rapids.
Cedar Rapids' 3.7% unemployment and limited life sciences employer density push specialized hiring toward CDMO/CRO partnerships, even as lab technician pay here lags the national median at $44,656 versus $47,402.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Cedar Rapids MSA unemployment: 3.7% — July 2026, down from 4.1% in June
- Iowa working population change: -7,500 — Year-over-year, largely retirement-driven
- Lab Technician advertised pay, metro: $44,656 — vs $47,402 national median
- VP Regulatory Affairs base pay range: $320K-$580K — National, reflects scarce senior regulatory talent
Key takeaways
Local talent scarcity makes outsourcing a default, not an option.
Limited life sciences employer density around Cedar Rapids means specialized regulatory and CMC searches compete against national biotech markets commanding $220K-$580K for director and VP-level roles. Organizations may find CDMO/CRO partnerships faster and more cost-predictable than sustained local recruiting for scarce credentialed talent.
Retirement-driven attrition is quietly shrinking Iowa's STEM pipeline.
Iowa's working population fell 7,500 year-over-year, largely attributed to retirement, compounding the challenge of replacing experienced scientific and quality talent in a state with few life sciences employers to begin with. Succession planning for senior technical roles deserves earlier attention than typical turnover models suggest.
Manufacturing's labor pull is a hidden competitor for technician talent.
August's 1,300 new manufacturing jobs statewide, alongside Cedar Rapids' established base at Collins Aerospace and Kraft Heinz, compete directly with life sciences for the same technician and quality-control labor pool. Advertised pay for lab technicians locally sits below the national median at $44,656 versus $47,402, suggesting local employers may need to sharpen offers to compete against better-known manufacturing brands.
National layoffs are reshuffling talent, not shrinking demand.
September's biopharma layoff announcements (BioMarin, Bristol Myers) reflect consolidation rather than contraction, with 64% of surveyed biopharma organizations still actively recruiting. Displaced regulatory and CMC specialists from larger markets may represent a sourcing opportunity for Cedar Rapids-area employers willing to support remote or relocation-friendly arrangements.
Median advertised pay by role — Cedar Rapids, IA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $74,181 | $104,805 | $112,429 | Significant increase | $131,354 |
| Clinical Research Associate * | $57,200 | $106,222 | $125,628 | Significant increase | $90,956 |
| Lab Technician * | $39,439 | $44,656 | $48,378 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $74,639 | $90,187 | $103,011 | Significant increase | $104,000 |
| Clinical Data Manager * | $74,125 | $89,187 | $112,693 | Significant decline | $123,031 |
| Biostatistician * | $86,372 | $110,253 | $146,269 | Moderate decline | $133,322 |
| Validation Engineer * | $118,498 | $121,331 | $123,498 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Cedar Rapids MSA unemployment held near 3.7% in July, consistent with four straight months of 3.2% statewide joblessness, as data center construction and manufacturing hiring absorb available labor while rents in Linn County climb faster than the rest of Iowa. A tight generalist labor market, combined with limited local biotech concentration beyond Boehringer Ingelheim Vetmedica's Ames footprint, means life sciences employers here compete for scientific and regulatory talent against capital-intensive industries bidding up the same regional labor pool.
What it means
Thin local density of specialized life sciences employers means Cedar Rapids-area organizations are effectively recruiting against national and coastal biotech hubs for regulatory, CMC, and quality talent rather than against nearby peers, widening the gap between what's advertised locally and what senior scientific hires actually expect. With Iowa's workforce shrinking due to retirement-driven attrition and manufacturing jobs absorbing the available labor surplus, build-vs-outsource calculus for clinical and manufacturing functions increasingly favors CDMO/CRO partnerships over attempting to grow captive R&D headcount in a market this thin. Consider evaluating whether specialized regulatory and CMC roles are better filled through flexible contract arrangements than through prolonged local recruiting cycles.
Looking ahead
Worth watching: Data center construction activity continues driving Linn County rent increases, which may pressure total rewards packages if cost-of-living adjustments become a recruiting talking point for relocating scientific talent.
Emerging pressure point: Iowa's new Career Training Physical Expansion Grants, effective mid-September, target apprenticeship capacity — a potential mid-term source of QA and manufacturing technician pipeline that life sciences employers should monitor for enrollment and placement timelines.
Early indicator: NFI Interactive Logistics' 49-worker layoff and RTX's smaller cuts by September 30 add modest displaced talent to the regional pool; watch whether any transferable quality or supply chain skills surface in life sciences applicant tracking.
Potential inflection point: National GLP-1 pipeline expansion is pulling manufacturing, quality, and regulatory talent toward concentrated biotech hubs — a trend that could widen the compensation gap Cedar Rapids employers face when competing for the same credentialed candidates.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.